Shopping Cart
- Remove All
Your shopping cart is currently empty
ML-309 is an inhibitor of mutant isocitrate dehydrogenase 1 (IDH1). It reversibly and selective inhibits IDH1R132H over wild-type IDH1 (IC50s = 96 and 36,500 nM, respectively). ML-309 reduces 2-hydroxyglutarate production in U87 MG glioblastoma cells (EC50 = 55 nM).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $142 | 35 days | |
| 5 mg | $383 | 35 days | |
| 10 mg | $685 | 35 days |
| Description | ML-309 is an inhibitor of mutant isocitrate dehydrogenase 1 (IDH1). It reversibly and selective inhibits IDH1R132H over wild-type IDH1 (IC50s = 96 and 36,500 nM, respectively). ML-309 reduces 2-hydroxyglutarate production in U87 MG glioblastoma cells (EC50 = 55 nM). |
| Molecular Weight | 521.03 |
| Formula | C29H30ClFN4O2 |
| Cas No. | 1355327-02-4 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Soluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.